Vijaya Diagnostic Centre Limited reported a robust performance for the second quarter of FY ’27, with consolidated revenue reaching approximately INR 255 crore, marking a significant year-on-year growth of 26.7%. The company’s profitability also saw a substantial increase, with EBITDA growing by 37.8% to INR 113 crore and profit after tax rising by 37.4% to INR 59 crore. Expansion plans include commissioning new hub and spoke centers and strategic acquisitions.
Strong Financial Performance in Q2 FY27
Vijaya Diagnostic Centre Limited announced a strong financial performance for the second quarter ended September 30, 2026 (Q2 FY ’27). The company achieved consolidated revenue of approximately INR 255 crore, a substantial increase of 26.7% compared to the same period last year. This growth was primarily driven by a 16.5% increase in test volumes, a favorable change in the test mix, and revisions in CGHS tariffs.
Profitability Enhancements
Profitability metrics also showed significant improvement. EBITDA for the quarter stood at approximately INR 113 crore, a growth of 37.8% year-on-year, with an EBITDA margin of 44.1%. Profit after tax for the quarter was INR 59 crore, up 37.4% year-on-year, resulting in a healthy PAT margin of 23.3%.
Half-Yearly Performance
For the half-year ended September 2026, consolidated revenue grew by 24.8% to INR 486 crore. EBITDA increased by 36% to INR 211 crore, maintaining a strong EBITDA margin of 43.4%. Profit after tax for the half-year was INR 113 crore with a PAT margin of 23.1%.
Geographical Contributions and Segment Performance
Hyderabad remained the largest contributor to revenue at 67%, followed by rest of AP Telangana (20%), Pune (5%), and West Bengal (5%). Revenue growth was driven by both the radiology and pathology segments, with B2C contributing 92% of revenue.
Expansion and Acquisition Update
The company continues its expansion, having commissioned two hub centers and seven spoke centers in the first half of the fiscal year. Plans include commissioning three additional hubs in the second half of FY ’27 and three more in Q1 FY ’28. In Hyderabad, plans are underway to establish a third flagship diagnostic center. The company has also entered into a business transfer agreement to acquire Arya Wellness Centre in Guwahati, Assam, marking its entry into the Northeast region. The acquisition is expected to be completed in the next two months.
Capital Expenditure Guidance
The estimated CAPEX for expansion projects, including the launch of 8 hub centers and 14 spokes by Q1 FY ’28, is expected to be approximately INR 155 crore to INR 160 crore. Several other CAPEX initiatives are planned, including upgrading equipment and building new facilities across various locations.
Source: BSE
